These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3414105)

  • 1. [Our experience in treating diabetes mellitus with the preparation Minidiab].
    Tsanev A; Lazarov G; Manolov D; Daskalova I; Kolebinov N
    Vutr Boles; 1988; 27(2):89-93. PubMed ID: 3414105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].
    Borisova AM; Taneva T; Koev D; Georgieva R
    Vutr Boles; 1988; 27(2):85-9. PubMed ID: 3137730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of Glipizide on the blood glucose and insulin in non-ketotic diabetes mellitus (author's transl)].
    Patsch W; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1976 Jan; 88(2):57-9. PubMed ID: 1258487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glipizide in the treatment of non-insulin-dependent diabetes mellitus].
    Luis Iriarte J
    Rev Clin Esp; 1989 Jun; 185(1):24-32. PubMed ID: 2772334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea.
    Allen BT; Feinglos MN; Lebovitz HE
    Arch Intern Med; 1985 Oct; 145(10):1900-3. PubMed ID: 3899039
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary results of non-insulin dependent diabetes mellitus treated with glipizide].
    Lu JM; Pan CY; Li CF
    Zhonghua Nei Ke Za Zhi; 1988 Mar; 27(3):143-6, 196. PubMed ID: 3219929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glipizide: a 2d generation sulfonamide and new antidiabetic].
    Deuil R
    Nouv Presse Med; 1975 Feb; 4(7):500-1. PubMed ID: 1093131
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.
    Greenfield MS; Doberne L; Rosenthal M; Vreman HJ; Reaven GM
    Arch Intern Med; 1982 Aug; 142(8):1498-1500. PubMed ID: 7103631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glipizide on platelet function and fibrinolytic activity.
    Ketsa K; Jererat S; Nitiyanant W; Suwanwattana K
    J Med Assoc Thai; 1987 Oct; 70(10):578-82. PubMed ID: 3694080
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J; Vandenberg M; Grunberger G
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus.
    Aman M; Jawad F; Sultana S; Waiz-ul-Haq ; Nanji R
    J Pak Med Assoc; 1977 Mar; 27(3):293-5. PubMed ID: 409862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus. Combined effects.
    Liu GC; Coulston AM; Lardinois CK; Hollenbeck CB; Moore JG; Reaven GM
    Arch Intern Med; 1985 Apr; 145(4):665-9. PubMed ID: 3885889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].
    Ferlito S; Lunetta M; Mangiagli P; Tranchida ML
    G Clin Med; 1974 Nov; 55(11):798-818. PubMed ID: 4469884
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.
    Tirkkonen T; Heikkilä P; Huupponen R; Laine K
    J Intern Med; 2010 Oct; 268(4):359-66. PubMed ID: 20698928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspectives in noninsulin-dependent diabetes mellitus and the role of glipizide in its treatment. Proceedings of a symposium.
    Am J Med; 1983 Nov; 75(5B):1-99. PubMed ID: 6673593
    [No Abstract]   [Full Text] [Related]  

  • 18. [A clinical study of a new sulfonylures hypoglycemic agent: glipizide (glibenese)(author's transl)].
    Cochet B; Balant L; Rilliet B; Zahnd G
    Schweiz Rundsch Med Prax; 1975 May; 64(18):562-8. PubMed ID: 1161734
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of glipizide. Results of a multicentric study in Spain].
    Cerdeño VM; Passigli AG; Calvet J; Soler J
    Rev Iber Endocrinol; 1975; 22(127):43-60. PubMed ID: 1145006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.